After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease

cafead

Administrator
Staff member
  • cafead   Feb 28, 2019 at 09:32: PM
via Equillium, a biotech that’s looking to develop an antibody drug for immuno-inflammatory diseases, has added a form of renal disease to the indications for which it aims to develop medicines.

article source